Person

John L. Higgins

Director, Bio-Techne

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$7.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 14, 2024TECHSale4,000$83.84$335K
Aug 11, 2022TECHSale504$385.47$194K
Aug 11, 2022TECHSale8$380.71$3K
Aug 10, 2022TECHSale100$374.90$37K
Aug 10, 2022TECHSale992$380.15$377K
Aug 10, 2022TECHSale900$373.99$337K
Jun 8, 2022TECHSale600$366.09$220K
Jun 7, 2022TECHSale1,000$364.31$364K
Nov 6, 2020TECHSale3,100$301.06$933K
Nov 6, 2020TECHSale1,450$298.98$434K
Nov 6, 2020TECHSale450$299.84$135K
Feb 12, 2020TECHSale5,000$205.23$1.0M
Jun 4, 2019TECHSale5,000$203.67$1.0M
Aug 23, 2018TECHSale10,000$187.92$1.9M
Sep 8, 2016TECHSale1,700$109.83$187K

SEC reporting-owner ID (CIK) 1208906 · all filings on EDGAR